Implication of indolamine 2,3 dioxygenase in the tolerance toward fetuses, tumors, and allografts

Journal of Leukocyte Biology

Volumn 93, Issue 5, 2013, Pages 681-687

  Dürr, Sophie ^a   Kindler, Vincent ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Autoimmunity; Cell therapy; Chronic disease; L tryptophan catabolism; Pregnancy; Trophoblast

Indexed keywords

ESSENTIAL AMINO ACID; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; TRYPTOPHAN HYDROXYLASE;

AUTOIMMUNE DISEASE; BIOCHEMISTRY; CANCER INHIBITION; ENDOMETRIUM; FETUS DEVELOPMENT; GENE EXPRESSION; GRAFT REJECTION; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; LISTERIA MONOCYTOGENES; NEOPLASM; ORGAN TRANSPLANTATION; PATHOGENESIS; PHAGOCYTE; PREGNANCY; PRIORITY JOURNAL; REVIEW; SALMONELLA TYPHIMURIUM; T LYMPHOCYTE; TOXOPLASMA GONDII; TROPHOBLAST;

MAMMALIA;

EID: 84877082935     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0712347     Document Type: Review

References (89)

1. Yuasa, H. J., Takubo, M., Takahashi, A., Hasegawa, T., Noma, H., Suzuki, T. (2007) Evolution of vertebrate indoleamine 2,3-dioxygenases. J. Mol. Evol. 65, 705-714.
2. Saito, K., Crowley, J. S., Markey, S. P., Heyes, M. P. (1993) A mechanism for increased quinolinic acid formation following acute systemic immune stimulation. J. Biol. Chem. 268, 15496-15503.
3. Metz, R., Duhadaway, J. B., Kamasani, U., Laury-Kleintop, L., Muller, A. J., Prendergast, G. C. (2007) Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan. Cancer Res. 67, 7082-7087.
4. Ball, H. J., Sanchez-Perez, A., Weiser, S., Austin, C. J., Astelbauer, F., Miu, J., McQuillan, J. A., Stocker, R., Jermiin, L. S., Hunt, N. H. (2007) Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice. Gene 396, 203-213.
5. Austin, C. J., Mailu, B. M., Maghzal, G. J., Sanchez-Perez, A., Rahlfs, S., Zocher, K., Yuasa, H. J., Arthur, J. W., Becker, K., Stocker, R., Hunt, N. H., Ball, H. J. (2010) Biochemical characteristics and inhibitor selectivity of mouse indoleamine 2,3-dioxygenase-2. Amino Acids 39, 565-578.
6. Lob, S., Konigsrainer, A., Zieker, D., Brucher, B. L., Rammensee, H. G., Opelz, G., Terness, P. (2009) IDO1 and IDO2 are expressed in human tumors: levo-but not dextro-1-methyl tryptophan inhibits tryptophan catabolism. Cancer Immunol. Immunother. 58, 153-157.
7. King, N. J., Thomas, S. R. (2007) Molecules in focus: indoleamine 2,3-dioxygenase. Int. J. Biochem. Cell Biol. 39, 2167-2172.
8. Thackray, S. J., Mowat, C. G., Chapman, S. K. (2008) Exploring the mechanism of tryptophan 2,3-dioxygenase. Biochem. Soc. Trans. 36, 1120-1123.
9. Suzuki, T., Yuasa, H., Imai, K. (1996) Convergent evolution. The gene structure of Sulculus 41 kDa myoglobin is homologous with that of human indoleamine dioxygenase. Biochim. Biophys. Acta 1308, 41-48.
10. Zelante, T., Fallarino, F., Bistoni, F., Puccetti, P., Romani, L. (2009) Indoleamine 2,3-dioxygenase in infection: the paradox of an evasive strategy that benefits the host. Microbes Infect. 11, 133-141.
11. Yuasa, H. J., Ball, H. J., Ho, Y. F., Austin, C. J., Whittington, C. M., Belov, K., Maghzal, G. J., Jermiin, L. S., Hunt, N. H. (2009) Characterization and evolution of vertebrate indoleamine 2, 3-dioxygenases IDOs from monotremes and marsupials. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 153, 137-144.
12. Yuasa, H. J., Hasegawa, T., Nakamura, T., Suzuki, T. (2007) Bacterial expression and characterization of molluscan IDO-like myoglobin. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 146, 461-469.
13. Yuasa, H. J., Ushigoe, A., Ball, H. J. (2011) Molecular evolution of bacterial indoleamine 2,3-dioxygenase. Gene 485, 22-31.
14. Hassanain, H. H., Chon, S. Y., Gupta, S. L. (1993) Differential regulation of human indoleamine 2,3-dioxygenase gene expression by interferons-γ and-α. Analysis of the regulatory region of the gene and identification of an interferon-γ-inducible DNA-binding factor. J. Biol. Chem. 268, 5077-5084.
15. Wan, H., Versnel, M. A., Leijten, L. M., van Helden-Meeuwsen, C. G., Fekkes, D., Leenen, P. J., Khan, N. A., Benner, R., Kiekens, R. C. (2008) Chorionic gonadotropin induces dendritic cells to express a tolerogenic phenotype. J. Leukoc. Biol. 83, 894-901.
16. Mellor, A. L., Munn, D. H. (2004) IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4, 762-774.
17. Popov, A., Abdullah, Z., Wickenhauser, C., Saric, T., Driesen, J., Hanisch, F. G., Domann, E., Raven, E. L., Dehus, O., Hermann, C., Eggle, D., Debey, S., Chakraborty, T., Kronke, M., Utermohlen, O., Schultze, J. L. (2006) Indoleamine 2,3-dioxygenase-expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection. J. Clin. Invest. 116, 3160-3170.
18. Dai, X., Zhu, B. T. (2010) Indoleamine 2,3-dioxygenase tissue distribution and cellular localization in mice: implications for its biological functions. J. Histochem. Cytochem. 58, 17-28.
19. Ryan, J. M., Barry, F., Murphy, J. M., Mahon, B. P. (2007) Interferon-γ does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin. Exp. Immunol. 149, 353-363.
20. Ottaviani, E., Franceschi, C. (1997) The invertebrate phagocytic immunocyte: clues to a common evolution of immune and neuroendocrine systems. Immunol. Today 18, 169-174.
21. Adams, O., Besken, K., Oberdorfer, C., MacKenzie, C. R., Takikawa, O., Daubener, W. (2004) Role of indoleamine-2,3-dioxygenase in α/β and γ interferon-mediated antiviral effects against herpes simplex virus infections. J. Virol. 78, 2632-2636.
22. Konen-Waisman, S., Howard, J. C. (2007) Cell-autonomous immunity to Toxoplasma gondii in mouse and man. Microbes Infect. 9, 1652-1661.
23. Knubel, C. P., Martinez, F. F., Fretes, R. E., Diaz Lujan, C., Theumer, M. G., Cervi, L., Motran, C. C. (2010) Indoleamine 2,3-dioxigenase (IDO) is critical for host resistance against Trypanosoma cruzi. FASEB J. 24, 2689-2701.
24. Rubin, B. Y., Anderson, S. L., Xing, L., Powell, R. J., Tate, W. P. (1991) Interferon induces tryptophanyl-tRNA synthetase expression in human fibroblasts. J. Biol. Chem. 266, 24245-24248.
25. Boasso, A., Herbeuval, J. P., Hardy, A. W., Winkler, C., Shearer, G. M. (2005) Regulation of indoleamine 2,3-dioxygenase and tryptophanyltRNA-synthetase by CTLA-4-Fc in human CD4+ T cells. Blood 105, 1574-1581.
26. Fleckner, J., Martensen, P. M., Tolstrup, A. B., Kjeldgaard, N. O., Justesen, J. (1995) Differential regulation of the human, interferon inducible tryptophanyl-tRNA synthetase by various cytokines in cell lines. Cytokine 7, 70-77.
27. Murray, M. F. (2003) Tryptophan depletion and HIV infection: a metabolic link to pathogenesis. Lancet Infect. Dis. 3, 644-652.
28. Munn, D. H., Sharma, M. D., Baban, B., Harding, H. P., Zhang, Y., Ron, D., Mellor, A. L. (2005) GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity 22, 633-642.
29. Kudo, Y., Boyd, C. A. (2001) Characterisation of L-tryptophan transporters in human placenta: a comparison of brush border and basal membrane vesicles. J. Physiol. 531, 405-416.
30. Zhu, L., Ji, F., Wang, Y., Zhang, Y., Liu, Q., Zhang, J. Z., Matsushima, K., Cao, Q. (2006) Synovial autoreactive T cells in rheumatoid arthritis resist IDO-mediated inhibition. J. Immunol. 177, 8226-8233.
31. Muller, A., Heseler, K., Schmidt, S. K., Spekker, K., Mackenzie, C. R., Daubener, W. (2009) The missing link between indoleamine 2,3-dioxygenase mediated antibacterial and immunoregulatory effects. J. Cell. Mol. Med. 13, 1125-1135.
32. Wang, S., Mao, C., Zhao, Z., Gu, Q., Jin, M., Xiao, Y., Jiang, X., Zhao, Y., Zhang, Y., Ning, G. (2009) Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine 36, 119-125.
33. Munn, D. H., Shafizadeh, E., Attwood, J. T., Bondarev, I., Pashine, A., Mellor, A. L. (1999) Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 189, 1363-1372.
34. Tse, W. T., Pendleton, J. D., Beyer, W. M., Egalka, M. C., Guinan, E. C. (2003) Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75, 389-397.
35. Le Blanc, K., Rasmusson, I., Sundberg, B., Gotherstrom, C., Hassan, M., Uzunel, M., Ringden, O. (2004) Treatment of severe acute graft-versushost disease with third party haploidentical mesenchymal stem cells. Lancet 363, 1439-1441.
36. Ringden, O., Uzunel, M., Rasmusson, I., Remberger, M., Sundberg, B., Lonnies, H., Marschall, H. U., Dlugosz, A., Szakos, A., Hassan, Z., Omazic, B., Aschan, J., Barkholt, L., Le Blanc, K. (2006) Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81, 1390-1397.
37. Kolodziej, L. R., Paleolog, E. M., Williams, R. O. (2011) Kynurenine metabolism in health and disease. Amino Acids 41, 1173-1183.
38. Barth, M. C., Ahluwalia, N., Anderson, T. J., Hardy, G. J., Sinha, S., Alvarez-Cardona, J. A., Pruitt, I. E., Rhee, E. P., Colvin, R. A., Gerszten, R. E. (2009) Kynurenic acid triggers firm arrest of leukocytes to vascular endothelium under flow conditions. J. Biol. Chem. 284, 19189-19195.
39. Takikawa, O., Yoshida, R., Kido, R., Hayaishi, O. (1986) Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase. J. Biol. Chem. 261, 3648-3653.
40. Fallarino, F., Grohmann, U., You, S., McGrath, B. C., Cavener, D. R., Vacca, C., Orabona, C., Bianchi, R., Belladonna, M. L., Volpi, C., Santamaria, P., Fioretti, M. C., Puccetti, P. (2006) The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor ζ-chain and induce a regulatory phenotype in naive T cells. J. Immunol. 176, 6752-6761.
41. Belladonna, M. L., Puccetti, P., Orabona, C., Fallarino, F., Vacca, C., Volpi, C., Gizzi, S., Pallotta, M. T., Fioretti, M. C., Grohmann, U. (2007) Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes. Transplantation 84, S17-S20.
42. Hoshi, M., Matsumoto, K., Ito, H., Ohtaki, H., Arioka, Y., Osawa, Y., Yamamoto, Y., Matsunami, H., Hara, A., Seishima, M., Saito, K. (2012) L-tryptophan-kynurenine pathway metabolites regulate type I IFNs of acute viral myocarditis in mice. J. Immunol. 188, 3980-3987.
43. Boasso, A., Hardy, A. W., Anderson, S. A., Dolan, M. J., Shearer, G. M. (2008) HIV-induced type I interferon and tryptophan catabolism drive T cell dysfunction despite phenotypic activation. PLoS One 3, e2961.
44. Criado, G., Simelyte, E., Inglis, J. J., Essex, D., Williams, R. O. (2009) Indoleamine 2,3 dioxygenase-mediated tryptophan catabolism regulates accumulation of Th1/Th17 cells in the joint in collagen-induced arthritis. Arthritis Rheum. 60, 1342-1351.
45. Schieve, L. A., Tatham, L., Peterson, H. B., Toner, J., Jeng, G. (2003) Spontaneous abortion among pregnancies conceived using assisted reproductive technology in the United States. Obstet. Gynecol. 101, 959-967.
46. Wang, J. X., Norman, R. J., Wilcox, A. J. (2004) Incidence of spontaneous abortion among pregnancies produced by assisted reproductive technology. Hum. Reprod. 19, 272-277.
47. Tummers, P., De Sutter, P., Dhont, M. (2003) Risk of spontaneous abortion in singleton and twin pregnancies after IVF/ICSI. Hum. Reprod. 18, 1720-1723.
48. Allen, W. R., Short, R. V. (1997) Interspecific and extraspecific pregnancies in equids: anything goes. J. Hered. 88, 384-392.
49. Chaouat, G., Petitbarat, M., Dubanchet, S., Rahmati, M., Ledee, N. (2010) Tolerance to the foetal allograft? Am. J. Reprod. Immunol. 63, 624-636.
50. Yamazaki, F., Kuroiwa, T., Takikawa, O., Kido, R. (1985) Human indolylamine 2,3-dioxygenase. Its tissue distribution, and characterization of the placental enzyme. Biochem. J. 230, 635-638.
51. Culouscou, J. M., Remacle-Bonnet, M. M., Pommier, G., Rance, R. J., Depieds, R. C. (1986) Immunosuppressive properties of human placenta: study of supernatants from short-term syncytiotrophoblast cultures. J. Reprod. Immunol. 9, 33-47.
52. Clark, D. A., Slapsys, R., Chaput, A., Walker, C., Brierley, J., Daya, S., Rosenthal, K. L. (1986) Immunoregulatory molecules of trophoblast and decidual suppressor cell origin at the maternofetal interface. Am. J. Reprod. Immunol. Microbiol. 10, 100-104.
53. Tafuri, A., Alferink, J., Moller, P., Hammerling, G. J., Arnold, B. (1995) T cell awareness of paternal alloantigens during pregnancy. Science 270, 630-633.
54. Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I., Conway, S. J., Marshall, B., Brown, C., Mellor, A. L. (1998) Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281, 1191-1193.
55. Baban, B., Chandler, P., McCool, D., Marshall, B., Munn, D. H., Mellor, A. L. (2004) Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific. J. Reprod. Immunol. 61, 67-77.
56. Kudo, Y., Boyd, C. A., Sargent, I. L., Redman, C. W. (2001) Tryptophan degradation by human placental indoleamine 2,3-dioxygenase regulates lymphocyte proliferation. J. Physiol. 535, 207-215.
57. Dong, M., Ding, G., Zhou, J., Wang, H., Zhao, Y., Huang, H. (2008) The effect of trophoblasts on T lymphocytes: possible regulatory effector molecules-a proteomic analysis. Cell. Physiol. Biochem. 21, 463-472.
58. Blaschitz, A., Gauster, M., Fuchs, D., Lang, I., Maschke, P., Ulrich, D., Karpf, E., Takikawa, O., Schimek, M. G., Dohr, G., Sedlmayr, P. (2011) Vascular endothelial expression of indoleamine 2,3-dioxygenase 1 forms a positive gradient towards the feto-maternal interface. PLoS One 6, e21774.
59. Zhu, B. T. (2010) Development of selective immune tolerance towards the allogeneic fetus during pregnancy: role of tryptophan catabolites (Review). Int. J. Mol. Med. 25, 831-835.
60. Wang, Y., Liu, H., McKenzie, G., Witting, P. K., Stasch, J. P., Hahn, M., Changsirivathanathamrong, D., Wu, B. J., Ball, H. J., Thomas, S. R., Kapoor, V., Celermajer, D. S., Mellor, A. L., Keaney, J. F., Jr., Hunt, N. H., Stocker, R. (2010) Kynurenine is an endothelium-derived relaxing factor produced during inflammation. Nat. Med. 16, 279-285.
61. Cudihy, D., Lee, R. V. (2009) The pathophysiology of pre-eclampsia: current clinical concepts. J. Obstet. Gynaecol. 29, 576-582.
62. Santoso, D. I., Rogers, P., Wallace, E. M., Manuelpillai, U., Walker, D., Subakir, S. B. (2002) Localization of indoleamine 2,3-dioxygenase and 4-hydroxynonenal in normal and pre-eclamptic placentae. Placenta 23, 373-379.
63. Kamimura, S., Eguchi, K., Yonezawa, M., Sekiba, K. (1991) Localization and developmental change of indoleamine 2,3-dioxygenase activity in the human placenta. Acta Med. Okayama 45, 135-139.
64. Sedlmayr, P. (2007) Indoleamine 2,3-dioxygenase in materno-fetal interaction. Curr. Drug Metab. 8, 205-208.
65. Schrocksnadel, K., Widner, B., Bergant, A., Neurauter, G., Schennach, H., Schrocksnadel, H., Fuchs, D. (2003) Longitudinal study of tryptophan degradation during and after pregnancy. Life Sci. 72, 785-793.
66. Riesenberg, R., Weiler, C., Spring, O., Eder, M., Buchner, A., Popp, T., Castro, M., Kammerer, R., Takikawa, O., Hatz, R. A., Stief, C. G., Hofstetter, A., Zimmermann, W. (2007) Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma. Clin. Cancer Res. 13, 6993-7002.
67. Batista, C. E., Juhasz, C., Muzik, O., Kupsky, W. J., Barger, G., Chugani, H. T., Mittal, S., Sood, S., Chakraborty, P. K., Chugani, D. C. (2009) Imaging correlates of differential expression of indoleamine 2,3-dioxygenase in human brain tumors. Mol. Imaging Biol. 11, 460-466.
68. Takikawa, O., Kuroiwa, T., Yamazaki, F., Kido, R. (1988) Mechanism of interferon-γ action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-γ and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity. J. Biol. Chem. 263, 2041-2048.
69. Uyttenhove, C., Pilotte, L., Theate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., Van den Eynde, B. J. (2003) Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat. Med. 9, 1269-1274.
70. Brandacher, G., Perathoner, A., Ladurner, R., Schneeberger, S., Obrist, P., Winkler, C., Werner, E. R., Werner-Felmayer, G., Weiss, H. G., Gobel, G., Margreiter, R., Konigsrainer, A., Fuchs, D., Amberger, A. (2006) Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. Clin. Cancer Res. 12, 1144-1151.
71. Weinlich, G., Murr, C., Richardsen, L., Winkler, C., Fuchs, D. (2007) Decreased serum tryptophan concentration predicts poor prognosis in malignant melanoma patients. Dermatology 214, 8-14.
72. Munn, D. H., Sharma, M. D., Hou, D., Baban, B., Lee, J. R., Antonia, S. J., Messina, J. L., Chandler, P., Koni, P. A., Mellor, A. L. (2004) Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J. Clin. Invest. 114, 280-290.
73. Wick, M., Dubey, P., Koeppen, H., Siegel, C. T., Fields, P. E., Chen, L., Bluestone, J. A., Schreiber, H. (1997) Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion or systemic anergy. J. Exp. Med. 186, 229-238.
74. Speiser, D. E., Miranda, R., Zakarian, A., Bachmann, M. F., McKall-Faienza, K., Odermatt, B., Hanahan, D., Zinkernagel, R. M., Ohashi, P. S. (1997) Self antigens expressed by solid tumors do not efficiently stimulate naive or activated T cells: implications for immunotherapy. J. Exp. Med. 186, 645-653.
75. Willimsky, G., Blankenstein, T. (2005) Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance. Nature 437, 141-146.
76. Willimsky, G., Blankenstein, T. (2007) The adaptive immune response to sporadic cancer. Immunol. Rev. 220, 102-112.
77. Cooper, E. L. (2009) eCAM: Darwin and Metchnikoff. Evid. Based Complement. Alternat. Med. 6, 421-422.
78. Qin, Z., Blankenstein, T. A (2004) A cancer immunosurveillance controversy. Nat. Immunol. 5, 3-4.
79. Erdman, S. E., Poutahidis, T., Tomczak, M., Rogers, A. B., Cormier, K., Plank, B., Horwitz, B. H., Fox, J. G. (2003) CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am. J. Pathol. 162, 691-702.
80. Pereira, A., Vottero, E., Roberge, M., Mauk, A. G., Andersen, R. J. (2006) Indoleamine 2,3-dioxygenase inhibitors from the Northeastern Pacific Marine Hydroid Garveia annulata. J. Nat. Prod. 69, 1496-1499.
81. Muller, A. J., Prendergast, G. C. (2005) Marrying immunotherapy with chemotherapy: why say IDO? Cancer Res. 65, 8065-8068.
82. Liu, X., Shin, N., Koblish, H. K., Yang, G., Wang, Q., Wang, K., Leffet, L., Hansbury, M. J., Thomas, B., Rupar, M., Waeltz, P., Bowman, K. J., Polam, P., Sparks, R. B., Yue, E. W., Li, Y., Wynn, R., Fridman, J. S., Burn, T. C., Combs, A. P., Newton, R. C., Scherle, P. A. (2010) Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity. Blood 115, 3520-3530.
83. Muller, A. J., DuHadaway, J. B., Donover, P. S., Sutanto-Ward, E., Prendergast, G. C. (2005) Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Nat. Med. 11, 312-319.
84. Brandacher, G., Margreiter, R., Fuchs, D. (2008) Clinical relevance of indoleamine 2,3-dioxygenase for alloimmunity and transplantation. Curr. Opin. Organ Transplant. 13, 10-15.
85. Li, Y., Tredget, E. E., Ghaffari, A., Lin, X., Kilani, R. T., Ghahary, A. (2006) Local expression of indoleamine 2,3-dioxygenase protects engraftment of xenogeneic skin substitute. J. Invest. Dermatol. 126, 128-136.
86. Sedlackova, L., Sosna, A., Vavrincova, P., Frydl, J., Guerriero, V., Raynes, D. A., Hromadnikova, I. (2011) Heat shock protein gene expression profile may differentiate between rheumatoid arthritis, osteoarthritis, and healthy controls. Scand. J. Rheumatol. 40, 354-357.
87. Sackstein, R., Merzaban, J. S., Cain, D. W., Dagia, N. M., Spencer, J. A., Lin, C. P., Wohlgemuth, R. (2008) Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nat. Med. 14, 181-187.
88. Crop, M. J., Baan, C. C., Korevaar, S. S., Ijzermans, J. N., Alwayn, I. P., Weimar, W., Hoogduijn, M. J. (2009) Donor-derived mesenchymal stem cells suppress alloreactivity of kidney transplant patients. Transplantation 87, 896-906.
89. Nowak, E. C., de Vries, V. C., Wasiuk, A., Ahonen, C., Bennett, K. A., Le Mercier, I., Ha, D. G., Noelle, R. J. (2012) Tryptophan hydroxylase-1 regulates immune tolerance and inflammation. J. Exp. Med. 209, 2127-2135.